Beyfortus
RSV outbreak causes shortage of Sanofi, AZ’s Beyfortus
Anika Sharma
Shortly after Sanofi and AstraZeneca secured a significant FDA approval for their respiratory syncytial virus (RSV) antibody, Beyfortus, the highly ...
Pfizer’s Abrysvo Achieves Landmark as First Maternal RSV Vaccine to Safeguard Newborns
Anika Sharma
Pfizer’s Abrysvo has achieved a groundbreaking milestone by becoming the first vaccine to safeguard newborns against respiratory syncytial virus (RSV) ...
Beyfortus: A Breakthrough RSV Shot for Infants Approved by CDC
SG Tylor
Source – Sanofi The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has given ...
FDA has approved Beyfortus as a treatment for RSV illness in newborns
SG Tylor
Source – Sanofi On July 17, 2023 Sanofi and AstraZeneca received approval from the US Food and Drug Administration (FDA) ...
